Drug Development in the New Era: A Global Perspective
4th International conference on phase 1 and early phase clinical trials
March 1-2, 2018 | Hyatt Regency Hong Kong, Tsim Sha Tsui, 18 Hanoi Road, Kowloon, Hong Kong
Professor Lee M. Ellis, MD
Professor of Surgery and Molecular & Cellular Biology
University of Texas MD Anderson Cancer Center, Houston, USA
Professor Lee M. Ellis completed a surgical oncology fellowship at the MD Anderson Cancer Center (MDACC), where he has been on the faculty since 1993. He has a clinical practice focused on patients with colorectal cancer and liver metastases. Professor Ellis has expertise in the area of angiogenesis and cell signaling in gastrointestinal malignancies and is funded by several grants. He has served on numerous NIH study sections and is active in the NCI, where he currently serves on the NCI Investigational Drug Steering Committee, is Vice Chair of the Colon Task Force and is co-chair of the NCI National Clinical Trials Network Correlative Sciences Committee. In 2000, Professor Ellis was the inaugural recipient of a grant from the George and Barbara Bush Endowment for Innovative Cancer Research. Professor Ellis is a Deputy Editor for JAMA Oncology.
Professor Ellis has authored over 240 peer-reviewed publications, and 110 invited reviews/editorials. He served as Co-Director for the ASCO/AACR Workshop on Methods in Clinical Cancer Research (MCCR) from 2010-2012, and now serves as Co-Director of the MCCR Workshop in Zeist, Netherlands. In 2013, he assumed the position of Vice Chair for Translational Medicine of SWOG. Professor Ellis recently chaired both the Nominating Committee and Cancer Research Committee of ASCO.
Day Two: Unbiased Approaches to Identify New Targets and Combination Therapies in CRC